Drug Approval | July 05, 2023
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
hubergroup’s two newly added medical vans are dedicated to dental and eye care
Mindset disagrees with and denies the allegations set forth from Reunion.
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
he product will be launched shortly in the US market.
Subscribe To Our Newsletter & Stay Updated
